Membrane technology

The Global Microdialysis Market is expected to grow by $ 0.86 mn during 2020-2024 progressing at a CAGR of 3% during the forecast period

Monday, September 21, 2020 - 3:20pm

The analyst has been monitoring the microdialysis market and it is poised to grow by $ 0.86 mn during 2020-2024 progressing at a CAGR of 3% during the forecast period.

Key Points: 
  • The analyst has been monitoring the microdialysis market and it is poised to grow by $ 0.86 mn during 2020-2024 progressing at a CAGR of 3% during the forecast period.
  • Our reports on microdialysis market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
  • The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.
  • The market is driven by the expanding applications of microdialysis, advantages of microdialysis over other methods, and growing popularity of the microdialysis technique in neuroscience research.

American Renal Associates Holdings, Inc. Announces Settlement of Shareholder Derivative Litigation

Friday, September 18, 2020 - 9:30pm

The proposed settlement releases all claims asserted against the Company and the other named defendants in the Johnson Action without any liability or wrongdoing attributed to them.

Key Points: 
  • The proposed settlement releases all claims asserted against the Company and the other named defendants in the Johnson Action without any liability or wrongdoing attributed to them.
  • Current shareholders may access a notice describing the proposed settlement and the agreement setting forth its terms on the Company's Investor Relations webpage.
  • American Renal Associates (ARA) is a leading provider of outpatient dialysis services in the United States.
  • For more information about American Renal Associates, visit www.americanrenal.com .

National Kidney Foundation Statement on the ESRD Treatment Choices Model (ETC) and Policies to Improve Kidney Patient Choice

Friday, September 18, 2020 - 6:44pm

NEW YORK, Sept. 18, 2020 /PRNewswire/ -- "The National Kidney Foundation (NKF) is pleased to support the three linchpin policies of the Advancing American Kidney Health (AAKH) initiative finalized this morning.

Key Points: 
  • NEW YORK, Sept. 18, 2020 /PRNewswire/ -- "The National Kidney Foundation (NKF) is pleased to support the three linchpin policies of the Advancing American Kidney Health (AAKH) initiative finalized this morning.
  • "The End Stage Renal Disease (ESRD) Treatment Choices Model finalized by the Center for Medicare and Medicaid Innovation (CMMI) today will dramatically increase the ability of patients to access kidney transplant and home dialysis , which are essential steps toward improving patient centric kidney care.
  • "Kidney transplant is the gold standard treatment for kidney failure for most patients, providing better health outcomes, an improved quality of life, and cost savings when compared to dialysis.
  • The National Kidney Foundation (NKF) is the largest, most comprehensive, and longstanding patient-centric organization dedicated to the awareness, prevention, and treatment of kidney disease in the U.S. For more information about NKF, visit www.kidney.org .

Essential Role of Ultrapure Dialysis Fluid Highlighted on World Patient Safety Day

Thursday, September 17, 2020 - 1:05am
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20200916005511/en/
    Fresenius Medical Care today announced the launch of the organizations first World Patient Safety Day initiative to raise awareness of the importance of ultrapure dialysis fluid for developing economies across Asia Pacific.
  • We have chosen World Patient Safety Day to highlight the importance of this issue.
  • These will begin with an online symposium presented on World Patient Safety Day, Does Ultrapure Dialysis Fluid Matter in Hemodialysis?
  • For more information about Ultrapure Dialysis Fluid, please visit: https://bit.ly/3moMk0Q
    The online symposium Does Ultrapure Dialysis Fluid Matter in Hemodialysis?

Dialysis Patient Citizens Commends Introduction of the BETTER Kidney Care Act

Wednesday, September 16, 2020 - 7:36pm

WASHINGTON, Sept. 16, 2020 /PRNewswire/ -- Dialysis Patient Citizens (DPC) today applauded introduction of theBETTER Kidney Care Act(H.R.

Key Points: 
  • WASHINGTON, Sept. 16, 2020 /PRNewswire/ -- Dialysis Patient Citizens (DPC) today applauded introduction of theBETTER Kidney Care Act(H.R.
  • "We applaud Senators Young and Sinema along with Representatives Blumenauer and Smith for introducing the BETTER Kidney Care Act.
  • "A study released in Health Affairs last week found a much higher survival rate for dialysis patients who participated in care coordination.
  • By establishing a system in which one entity takes responsibility for the overall care of their dialysis patient, theBETTER Kidney Care Actwould help to keep patients healthy, prevent unwanted complications, and reduce overall healthcare costs.

Membrane Contactor Market worth $340 Million by 2025 - Exclusive Report by MarketsandMarkets™

Tuesday, September 15, 2020 - 3:00pm

Based on application, the membrane contactor market has been classified into the food processing, pharmaceuticals processing, water & wastewater treatment, microelectronics & semiconductors, power & steam generation, oil & gas, and others segments.

Key Points: 
  • Based on application, the membrane contactor market has been classified into the food processing, pharmaceuticals processing, water & wastewater treatment, microelectronics & semiconductors, power & steam generation, oil & gas, and others segments.
  • Based on membrane, the global membrane contactor market is segregated into polypropylene, polytetrafluoroethylene and others including membranes made of materials such as PMP, PFA, PVDF and composites.
  • This is because membrane contactors commercialized under the brand Liqui-Cel by the 3M Company generally use polypropylene microporous hollow fiber membrane.
  • Based on region, the membrane contactor market has been segmented into Asia Pacific, North America, Europe, the Middle East & Africa, and South America.

Membrane Contactor Market worth $340 Million by 2025 - Exclusive Report by MarketsandMarkets™

Tuesday, September 15, 2020 - 3:00pm

Based on application, the membrane contactor market has been classified into the food processing, pharmaceuticals processing, water & wastewater treatment, microelectronics & semiconductors, power & steam generation, oil & gas, and others segments.

Key Points: 
  • Based on application, the membrane contactor market has been classified into the food processing, pharmaceuticals processing, water & wastewater treatment, microelectronics & semiconductors, power & steam generation, oil & gas, and others segments.
  • Based on membrane, the global membrane contactor market is segregated into polypropylene, polytetrafluoroethylene and others including membranes made of materials such as PMP, PFA, PVDF and composites.
  • This is because membrane contactors commercialized under the brand Liqui-Cel by the 3M Company generally use polypropylene microporous hollow fiber membrane.
  • Based on region, the membrane contactor market has been segmented into Asia Pacific, North America, Europe, the Middle East & Africa, and South America.

Ardelyx Announces FDA Acceptance for Filing of its New Drug Application of Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis

Tuesday, September 15, 2020 - 1:00pm

This is a special time for the Ardelyx team as we have a clear mission that we can and should do better for patients.

Key Points: 
  • This is a special time for the Ardelyx team as we have a clear mission that we can and should do better for patients.
  • We believe that with tenapanor, we have discovered and developed a therapy that will truly advance care for patients on dialysis."
  • The FDA has set a Prescription Drug User Fee Act (PDUFA) goal date of April 29, 2021.
  • Tenapanor, discovered and developed by Ardelyx, is a first-in-class, proprietary, oral medicine for which an NDA is under review by the FDA for the control of serum phosphorus in adult patients with CKD on dialysis.

Quanta to Host Expert Perspectives Webinar on Home Dialysis

Tuesday, September 15, 2020 - 12:00pm

Alcester, Warwickshire, UK, 15 September 2020: Quanta Dialysis Technologies Ltd (Quanta or the Company), a British medical technology innovation company, today announces that it will be hosting an Expert Perspectives Webinar on home dialysis on Monday 21 September at 4pm BST / 11am EDT.

Key Points: 
  • Alcester, Warwickshire, UK, 15 September 2020: Quanta Dialysis Technologies Ltd (Quanta or the Company), a British medical technology innovation company, today announces that it will be hosting an Expert Perspectives Webinar on home dialysis on Monday 21 September at 4pm BST / 11am EDT.
  • The presentation will be followed by a live moderated Q&A with the panel and audience by Tina Tan, Executive Editor at FirstWord MedTech.
  • The management team at Quanta Dialysis Technologies will also be available to discuss SC+, its small, simple and versatile haemodialysis system.
  • How quickly will dialysis be adopted routinely in North America?

Quanta to Host Expert Perspectives Webinar on Home Dialysis

Tuesday, September 15, 2020 - 8:00am

Alcester, Warwickshire, UK, 15 September 2020: Quanta Dialysis Technologies Ltd (Quanta or the Company), a British medical technology innovation company, today announces that it will be hosting an Expert Perspectives Webinar on home dialysis on Monday 21 September at 4pm BST / 11am EDT.

Key Points: 
  • Alcester, Warwickshire, UK, 15 September 2020: Quanta Dialysis Technologies Ltd (Quanta or the Company), a British medical technology innovation company, today announces that it will be hosting an Expert Perspectives Webinar on home dialysis on Monday 21 September at 4pm BST / 11am EDT.
  • The presentation will be followed by a live moderated Q&A with the panel and audience by Tina Tan, Executive Editor at FirstWord MedTech.
  • The management team at Quanta Dialysis Technologies will also be available to discuss SC+, its small, simple and versatile haemodialysis system.
  • How quickly will dialysis be adopted routinely in North America?